Target intelligence / Profile preview

Cytochrome c protein (Cyt c)

Target
Cyt c
Molecular classification
Enzyme, All-α protein, Heme protein, Mitochondrial protein
01

Overview

Cytochrome c protein is a small, highly conserved, water-soluble heme protein located in the mitochondrial intermembrane space, where it plays a central role as an electron carrier in the respiratory chain by transferring electrons from complex III (cytochrome bc1 complex) to complex IV (cytochrome c oxidase), ultimately supporting ATP synthesis. It consists of about 104 amino acids, contains a covalently-bound heme group, and has a distinctive structure involving five α-helices with a characteristic CXXCH motif for heme binding. Upon mitochondrial outer membrane permeabilization, cytochrome c is released into the cytosol, where it acts as a major pro-apoptotic factor by activating caspase enzymes, thereby regulating cell death pathways. Its essentiality in energy metabolism, role in apoptosis, and high level of evolutionary conservation make it a key molecule in both physiology and disease research.

Other names
Cytochrome cCyt cC-type cytochrome
02

Mechanism of action

Induction of apoptosis (agents may promote cytochrome c release from mitochondria, leading to activation of caspases) Electron transfer disruption (toxins/drugs inhibit mitochondrial complexes, leading to functional blockade of cytochrome c’s electron shuttling) Oxidative stress modulation (agents may influence cytochrome c’s peroxidase activity)

03

Biological functions

Electron transportApoptosisReactive oxygen species detoxificationHydroxylation, redox catalysis, peroxidase activity
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Targeting cytochrome c risks widespread apoptosis/cell deathOff-target effects due to high sequence and structural conservation across speciesEssentiality for energy metabolism: Inhibition or loss can be lethal for non-target cells
06

Interacting drugs

No FDA-approved drugs directly target cytochrome c in clinical use. Some experimental or investigational compounds and peptides modulate its release or function (e.g., apoptosis inducers in cancer research). Indirect interactions occur with drugs affecting the mitochondrial electron transport chain (e.g., antimycin, cyanide, which target related complexes).
07

Biomarkers

Cytosolic cytochrome cRelease during myocardial infarction and stroke

Beyond the preview

Go deeper on Cytochrome c protein (Cyt c).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c protein (Cyt c).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call